S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Pluristem to Deliver Scientific Presentations at 3rd International Placenta Stem Cell Society Meeting|
|United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension|
|Pluristem to Present at Financial Conferences in New York City on September 10th and 17th, 2014|
|Pluristem Wins Cell Therapy Patent Case in Europe; European Patent Office Confirms Validity of Amended Claims|
|Pluristem Advances Its Second Major Cell Therapy Product Line From Development to Large-Scale Manufacturing|
|Case Western Reserve University to Study Pluristem's PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases|
|Pluristem CEO Zami Aberman to Present at Two Regenerative Medicine Conferences in London on November 12 and 13, 2014|
|Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications|
|Pluristem's Dr. Ohad Karnieli to Present at Two Upcoming Scientific Conferences|
|Pluristem Granted Patent in Singapore for Its 3D Cell Expansion Technology|
Click above to view more mutual fund data and stats for 4109 - Stella Chemifa Corp.